Sarepta Therapeutics (SRPT) Assets (2010 - 2026)
Sarepta Therapeutics' quarterly Assets came in at $3.2 billion in Q1 2026, down 8.27% year-on-year from $3.5 billion in Q1 2025, and down 5.1% quarter-over-quarter from $3.3 billion in Q4 2025.
Sarepta Therapeutics has reported Assets for 17 years, with the latest figure at $3.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Assets fell 8.27% year-over-year to $3.2 billion; the trailing twelve-month figure through Mar 2026 stood at $3.2 billion (down 8.27% YoY), and the FY2025 full-year result was $3.3 billion, down 15.48% from the prior year.
- Assets for Q1 2026 stood at $3.2 billion, down from $3.3 billion in the prior quarter.
- The five-year high for Assets was $4.0 billion in Q4 2024, with the low at $3.0 billion in Q2 2022.
- Average Assets over 5 years is $3.3 billion, with a median of $3.2 billion recorded in 2024.
- Year-over-year, Assets increased 21.4% in 2024 and declined 15.48% in 2025.
- Tracing SRPT's Assets over 5 years: stood at $3.1 billion in 2022, then increased by 4.35% to $3.3 billion in 2023, then grew by 21.4% to $4.0 billion in 2024, then decreased by 15.48% to $3.3 billion in 2025, then declined by 5.1% to $3.2 billion in 2026.
- The last three Assets figures came in at $3.2 billion (Q1 2026), $3.3 billion (Q4 2025), and $3.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 3.18 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.18 Bn |
| Dec 31, 2025 | 3.35 Bn |
| Sep 30, 2025 | 3.49 Bn |
| Jun 30, 2025 | 3.68 Bn |
| Mar 31, 2025 | 3.47 Bn |
| Dec 31, 2024 | 3.96 Bn |
| Sep 30, 2024 | 3.60 Bn |
| Jun 30, 2024 | 3.42 Bn |
| Mar 31, 2024 | 3.22 Bn |
| Dec 31, 2023 | 3.26 Bn |
| Sep 30, 2023 | 3.11 Bn |
| Jun 30, 2023 | 3.13 Bn |
| Mar 31, 2023 | 3.06 Bn |
| Dec 31, 2022 | 3.13 Bn |
| Sep 30, 2022 | 3.16 Bn |
| Jun 30, 2022 | 3.00 Bn |
| Mar 31, 2022 | 3.06 Bn |
| Dec 31, 2021 | 3.15 Bn |
| Sep 30, 2021 | 2.66 Bn |
| Jun 30, 2021 | 2.76 Bn |
| Mar 31, 2021 | 2.77 Bn |
| Dec 31, 2020 | 2.98 Bn |
| Sep 30, 2020 | 2.78 Bn |
| Jun 30, 2020 | 2.88 Bn |
| Mar 31, 2020 | 2.95 Bn |
| Dec 31, 2019 | 1.82 Bn |
| Sep 30, 2019 | 1.70 Bn |
| Jun 30, 2019 | 1.75 Bn |
| Mar 31, 2019 | 1.96 Bn |
| Dec 31, 2018 | 1.64 Bn |
| Sep 30, 2018 | 1.18 Bn |
| Jun 30, 2018 | 1.25 Bn |
| Mar 31, 2018 | 1.30 Bn |
| Dec 31, 2017 | 1.31 Bn |
| Sep 30, 2017 | 800.28 Mn |
| Jun 30, 2017 | 450.14 Mn |
| Mar 31, 2017 | 511.53 Mn |
| Dec 31, 2016 | 424.10 Mn |
| Sep 30, 2016 | 487.31 Mn |
| Jun 30, 2016 | 204.07 Mn |
| Mar 31, 2016 | 213.36 Mn |
| Dec 31, 2015 | 273.78 Mn |
| Sep 30, 2015 | 184.75 Mn |
| Jun 30, 2015 | 231.71 Mn |
| Mar 31, 2015 | 242.71 Mn |
| Dec 31, 2014 | 295.03 Mn |
| Sep 30, 2014 | 319.06 Mn |
| Jun 30, 2014 | 337.31 Mn |
| Mar 31, 2014 | 275.39 Mn |
| Dec 31, 2013 | 291.57 Mn |
| Sep 30, 2013 | 304.48 Mn |
| Jun 30, 2013 | 183.63 Mn |
| Mar 31, 2013 | 193.34 Mn |
| Dec 31, 2012 | 204.99 Mn |
| Mar 31, 2012 | 46.65 Mn |
| Dec 31, 2011 | 54.37 Mn |
| Sep 30, 2011 | 61.08 Mn |
| Jun 30, 2011 | 74.93 Mn |
| Dec 31, 2010 | 45.98 Mn |